Biomerica Inc. (NASDAQ:BRMA) of Newport Beach, Calif.,announced that it has developed an ELISA test kit for detectingthyroglobulin autoantibodies in blood samples from patientswith asymptomatic chronic thyroiditis, as well as patients whohave been treated for thyroid diseases such as goiter, Graves'and Hashimoto's diseases.

(c) 1997 American Health Consultants. All rights reserved.

No Comments